Linezolid Teva

Linezolid, the active ingredient in Linezolid Teva, is an oxazolidinone presented as an oral tablet for oral use. It treats serious bacterial infections such as complicated skin and soft‑tissue infections, community‑acquired pneumonia and infections caused by MRSA or VRE in adult patients. GNH USA supplies Linezolid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is indicated for bacterial infections that require activity against resistant Gram‑positive organisms. - Complicated skin and soft‑tissue infections: provides effective coverage of MRSA and other resistant pathogens. - Community‑acquired bacterial pneumonia: treats typical and atypical organisms, including resistant strains. - Infections caused by vancomycin‑resistant Enterococcus (VRE): offers an oral therapeutic option when other agents are limited.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Metallic taste: altered taste perception. - Vomiting: occasional emesis. - Insomnia: difficulty sleeping.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced red blood cell levels. - Peripheral neuropathy: tingling or numbness in extremities. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: metabolic disturbance. - Optic neuropathy: visual disturbances, potentially irreversible.

Before initiating therapy, clinicians should consider several safety measures. - Monitor blood counts: watch for thrombocytopenia and anemia. - Assess renal and hepatic function: adjust use in impairment. - Avoid serotonergic drugs: risk of serotonin syndrome. - Use cautiously in seizure history: potential for CNS effects. - Evaluate for myelosuppression: regular laboratory monitoring recommended. - Store at below 25°C: keep in the original pack, protect from moisture.

Linezolid interacts with several medication classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): can precipitate hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, tricyclic antidepressants): risk of serotonin syndrome. - Rifampin: induces metabolism, reducing linezolid exposure. - Anticonvulsants (phenytoin, carbamazepine): may lower efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR, requiring dose adjustment. - NSAIDs: heightened bleeding risk. - Digoxin: potential for increased serum levels. - Ethanol: may exacerbate CNS depression. - Oral contraceptives: possible reduced effectiveness.